chr15-43197420-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001114134.2(EPB42):c.1958A>T(p.Gln653Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,614,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001114134.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EPB42 | NM_001114134.2 | c.1958A>T | p.Gln653Leu | missense_variant | 13/13 | ENST00000441366.7 | NP_001107606.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EPB42 | ENST00000441366.7 | c.1958A>T | p.Gln653Leu | missense_variant | 13/13 | 1 | NM_001114134.2 | ENSP00000396616 | P1 | |
EPB42 | ENST00000567019.2 | n.1464A>T | non_coding_transcript_exon_variant | 8/8 | 1 | |||||
EPB42 | ENST00000648595.1 | c.2048A>T | p.Gln683Leu | missense_variant | 13/13 | ENSP00000497777 | ||||
EPB42 | ENST00000540029.5 | c.1724A>T | p.Gln575Leu | missense_variant | 12/12 | 2 | ENSP00000444699 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152150Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461888Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 727246
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152150Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74314
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 19, 2024 | The c.2048A>T (p.Q683L) alteration is located in exon 13 (coding exon 13) of the EPB42 gene. This alteration results from a A to T substitution at nucleotide position 2048, causing the glutamine (Q) at amino acid position 683 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at